Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
InSite Vision |
---|---|
Information provided by: | InSite Vision |
ClinicalTrials.gov Identifier: | NCT00105534 |
The purpose of this study is to evaluate the clinical and microbial efficacy and safety of AzaSite compared to vehicle for bacterial conjunctivitis. Adults and children one year of age and older with bacterial conjunctivitis in at least one eye may be eligible. Subjects will be randomly assigned to receive either 1.0 % AzaSite or Vehicle. Three visits will be required for this study.
Condition | Intervention | Phase |
---|---|---|
Bacterial Conjunctivitis |
Drug: AzaSite |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Study to Evaluate the Clinical and Microbial Efficacy and Safety of 1.0 % AzaSite Compared to Vehicle in the Treatment of Bacterial Conjunctivitis |
Ages Eligible for Study: | 12 Months and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | C-01-401-03 |
Study First Received: | March 15, 2005 |
Last Updated: | March 12, 2007 |
ClinicalTrials.gov Identifier: | NCT00105534 |
Health Authority: | United States: Food and Drug Administration |
Bacterial Conjunctivitis Pink Eye Conjunctivitis Eye Infection Eye Discharge |
Bacterial Infections Eye Infections, Bacterial Conjunctivitis, Bacterial Azithromycin |
Eye Diseases Eye Infections Conjunctivitis Conjunctival Diseases |
Infection |